PMC9940130_01
Electrocardiogram shows atrial fibrillation with rapid ventricular response
cureus-0015-00000033930-i01.jpg
PMC9940130_01_cureus-0015-00000033930-i01.jpg
FIG1
Two months later, in April 2022, the patient attended her local accident and emergency with symptomatic atrial tachycardia with rapid ventricular response despite being on verapamil, amiodarone, and digoxin, which the treating team were unable to chemically cardiovert or control (Figure 1).
Chest radiography shows dual chamber pacemaker in situ
cureus-0015-00000033930-i02.jpg
PMC9940130_01_cureus-0015-00000033930-i02.jpg
FIG2
A post-PPM implant chest X-ray confirmed satisfactory lead positioning when compared to fluoroscopic images during the PPM insertion (Figure 2).
Parasternal long-axis view showing impaired left ventricular systolic function. Apical four chambers view shows severely impaired left ventricular systolic function. Parasternal short-axis view shows severely impaired left ventricular systolic function. Cardiac resynchronization therapy pacemaker video with three leads including left ventricular lead
.jpg
PMC9940130_01_.jpg
VID1
Her device was upgraded to a cardiac resynchronization therapy pacemaker (CRT-P) device with a pacing function in November 2022 with the introduction of a left ventricular lead via the coronary sinus (Figure 3 and Video 4).
Chest radiograph showing CRT-P in situ. CRT-P: cardiac resynchronization therapy pacemaker
cureus-0015-00000033930-i03.jpg
PMC9940130_01_cureus-0015-00000033930-i03.jpg
FIG3
Her device was upgraded to a cardiac resynchronization therapy pacemaker (CRT-P) device with a pacing function in November 2022 with the introduction of a left ventricular lead via the coronary sinus (Figure 3 and Video 4).